Tubal ligation during cesarean delivery and future risk for ovarian cancer: a population-based cohort study

被引:6
作者
Kessous, Roy [1 ]
Sergienko, Ruslan [2 ]
Sheiner, Eyal [1 ]
机构
[1] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Fac Hlth Sci, Dept Obstet & Gynecol, POB 151, IL-84101 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Dept Publ Hlth, Beer Sheva, Israel
关键词
Bilateral tubal ligation; Cesarean delivery; Ovarian cancer; EPITHELIAL OVARIAN; BILATERAL SALPINGECTOMY; STERILIZATION; HYSTERECTOMY; MORTALITY; TRENDS; TUMORS;
D O I
10.1007/s00404-020-05547-w
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective Data regarding the effect of post-partum bilateral tubal ligation (BTL) on future risk for ovarian cancer (OC) is lacking. In the current study, we aimed to evaluate the effect of BTL during cesarean delivery (CD) on the long-term risk for OC. Study design A population-based cohort analysis of women above the age of 35 that underwent CD in their last delivery, comparing the long-term risk for OC between patients that had a Pomeroy excisional BTL and those that did not. OC diagnosis was pre-defined based on ICD-9 codes. Procedures occurred between the years 1991-2017. Kaplan-Meier survival curve was used to compare the cumulative incidence of OC over time and Cox proportional hazards model was constructed to control for confounders. Results During the study period 13,124 women met the inclusion criteria; 9438 (71.9%) of which had only CD and 3686 (28.1%) underwent CD with BTL. Despite the significantly higher incidence of maternal factors that might increase the long-term risk for OC in the BTL group (advanced maternal age, obesity, hypertensive diseases during pregnancy and diabetes mellitus), the cumulative incidence of OC cases was not significantly different between the two groups (Log-rank test p = 0.199). Likewise, when performing a Cox regression model controlling for maternal age, obesity, hypertensive diseases and diabetes, OC risk was not significantly different between the groups (adjusted HR 2.36, 95% CI 0.73-7.62; p = 0.149). Conclusion Despite an increased incidence of known risk factors for OC, patients that underwent BTL during CD did not have increased long-term risk for OC.
引用
收藏
页码:1473 / 1477
页数:5
相关论文
共 50 条
[41]   Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study [J].
Lundberg, Frida E. ;
Johansson, Anna L. V. ;
Rodriguez-Wallberg, Kenny ;
Gemzell-Danielsson, Kristina ;
Iliadou, Anastasia N. .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2019, 34 (11) :1093-1101
[42]   Oral bisphosphonate use and the risk of female breast, ovarian, and cervical cancer: a nationwide population-based cohort study [J].
Bae, Ye Seul ;
Chang, Jooyoung ;
Park, Sang Min .
ARCHIVES OF OSTEOPOROSIS, 2019, 14 (01)
[43]   Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study [J].
Frida E. Lundberg ;
Anna L. V. Johansson ;
Kenny Rodriguez-Wallberg ;
Kristina Gemzell-Danielsson ;
Anastasia N. Iliadou .
European Journal of Epidemiology, 2019, 34 :1093-1101
[44]   Oral bisphosphonate use and the risk of female breast, ovarian, and cervical cancer: a nationwide population-based cohort study [J].
Ye Seul Bae ;
Jooyoung Chang ;
Sang Min Park .
Archives of Osteoporosis, 2019, 14
[45]   Population-based risk for peripartum hysterectomy during low- and moderate-risk delivery hospitalizations [J].
Friedman, Alexander M. ;
Wright, Jason D. ;
Ananth, Cande V. ;
Siddiq, Zainab ;
D'Alton, Mary E. ;
Bateman, Brian T. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (05) :640.e1-640.e8
[46]   Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based study [J].
Kuan, Ai-Seon ;
Teng, Chung-Jen ;
Wu, Hua-Hsi ;
Su, Vincent Yi-Fong ;
Chen, Yung-Tai ;
Chien, Sheng-Hsuan ;
Yeh, Chiu-Mei ;
Hu, Li-Yu ;
Chen, Tzeng-Ji ;
Tzeng, Cheng-Hwai ;
Liu, Chia-Jen .
BMC MEDICINE, 2014, 12
[47]   Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based study [J].
Ai-Seon Kuan ;
Chung-Jen Teng ;
Hua-Hsi Wu ;
Vincent Yi-Fong Su ;
Yung-Tai Chen ;
Sheng-Hsuan Chien ;
Chiu-Mei Yeh ;
Li-Yu Hu ;
Tzeng-Ji Chen ;
Cheng-Hwai Tzeng ;
Chia-Jen Liu .
BMC Medicine, 12
[48]   Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study [J].
Sigrun A Johannesdottir ;
Morten Schmidt ;
Gary Phillips ;
Ronald Glaser ;
Eric V Yang ;
Michael Blumenfeld ;
Stanley Lemeshow .
BMC Cancer, 13
[49]   Genitourinary disease risks among ovarian cancer survivors in a population-based cohort study [J].
Chang, Chun-Pin ;
Chen, Yuji ;
Blackburn, Brenna ;
Abdelaziz, Sarah ;
Rowe, Kerry ;
Snyder, John ;
Dodson, Mark ;
Deshmukh, Vikrant ;
Newman, Michael ;
Stanford, Joseph B. ;
Porucznik, Christina A. ;
Ose, Jennifer ;
Fraser, Alison ;
Smith, Ken ;
Doherty, Jennifer ;
Gaffney, David ;
Hashibe, Mia .
GYNECOLOGIC ONCOLOGY, 2020, 157 (02) :529-535
[50]   Statin use and mortality among ovarian cancer patients: A population-based cohort study [J].
Verdoodt, Freija ;
Hansen, Merete Kjaer ;
Kjaer, Susanne K. ;
Pottegard, Anton ;
Friis, Soren ;
Dehlendorff, Christian .
INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (02) :279-286